| Category: |
Antibody |
| Concentration: |
2ml sterile DI water, 5mg/ml if reconstituted with 0 |
| Form: |
Antigen affinity purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
VEGFD / VEGF4 |
| Host animal: |
Rabbit (Oryctolagus cuniculus) |
| Clonality: |
Polyclonal (rabbit origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
WB |
| Recommended dilutions: |
1-0, 5ug/ml, Western blot: 0 |
| Notes: |
Optimal dilution of the VEGFD antibody should be determined by the researcher |
| Intented use: |
This VEGFD antibodyis to be used only for research purposes and not for diagnostics |
| Uniprot #: |
O43915 |
| Purity: |
Antigen affinity |
| Description: |
(1997) symbolized VEGFD, (1998) concluded that VEGFD was most closely related to VEGFC by virtue of the presence of N- and C-terminal extensions that were not found in other VEGF family members, (2001) showed that VEGFD can induce tumor angiogenesis through VEGFR2 and tumor lymphangiogenesis through VEGFR3, Analyzing by Northern blotting, And Achen et al, Stacker et al, The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family and is active in angiogenesis, VEGF4) is a vascular endothelial growth factor that in humans is encoded by the FIGF gene, VEGFD, Yamada et al, and endothelial cell growth, and fetal lung, and lower levels in skeletal muscle, and pancreas, colon, heart, induces only tumor angiogenesis, lymphangiogenesis, small intestine, was expressed as a 2, whereas VEGF, which does not activate VEGFR3, 2-kb transcript with highest expression in lung, C-fos induced growth factor (FIGF) (or vascular endothelial growth factor D |
| Immunogen: |
Amino acids 89-205 of human VEGFD were used as the immunogen for the VEGFD antibody |
| Storage: |
Avoid repeated freezing and thawing, Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, aliquot and store at -20 deg, the VEGFD antibody may be kept for up to one month refrigerated at +4 degrees C, After reconstitution, For long-term |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
VEGFD / VEGF4 |
| Short name: |
VEGFD Antibody / VEGF4 |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
VEGFD (Antibody to) / VEGF4 |
| Alternative technique: |
antibodies |
| Identity: |
3708 |
| Gene: |
VEGFD |
More about : VEGFD |
| Long gene name: |
vascular endothelial growth factor D |
| Synonyms gene: |
FIGF |
| Synonyms gene name: |
c-fos induced growth factor (vascular endothelial growth factor D) |
| Synonyms: |
VEGF-D |
| Locus: |
Xp22, 2 |
| Discovery year: |
1997-03-27 |
| GenBank acession: |
AJ000185 |
| Entrez gene record: |
2277 |
| Pubmed identfication: |
9479493 |
| RefSeq identity: |
NM_004469 |
| Classification: |
VEGF family |
| Havana BLAST/BLAT: |
OTTHUMG00000021175 |
| Locus Specific Databases: |
Mental Retardation database |